IPR2023-00249 - Dana Farber Cancer Institute Inc v. Bristol Myers Squibb Co

Details
PATENT NUMBER
10323092 Medical
APPL. NUMBER
16006493
PETITIONER
Dana Farber Cancer Institute Inc
University
PATENT OWNER
Bristol Myers Squibb Co
Operating Company
STATUS
Settlement
FILING DATE
2022-12-29
INSTITUTION DATE
N/A
TERMINATION DATE
2023-04-10
PET. COUNSEL
Dechert LLP
P.O. COUNSEL
Akin Gump Strauss Hauer & Feld LLP
AUTHOR JUDGE
Timeline
Petition
Notice of Filing Date
Motion to Terminate
Final Decision
Dec
2023
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2024
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2025
Feb
Mar
Apr
May
Docket
Paper No.
Date
Party
Type
Name
12022-12-29PetitionerPetitionPetition for Inter Partes Review
22022-12-29PetitionerPower of AttorneyPetitioner's Power of Attorney
10012022-12-29PetitionerU.S. Patent No. 10,323,092 B2
10022022-12-29PetitionerDeclaration of Dr. Salma Jabbour
10032022-12-29PetitionerDeclaration of Robert Paarlberg
10042022-12-29PetitionerCurriculum vitae of Dr. Salma Jabbour
10052022-12-29PetitionerCurriculum vitae of Robert Paarlberg
10062022-12-29PetitionerList of Materials Considered by Dr. Salma Jabbour
10072022-12-29PetitionerList of Materials Considered by Robert Paarlberg
10082022-12-29PetitionerJune 8, 2022, Letter to Hon. Kathi Vidal from Senators Leahy, Cornyn,...
10092022-12-29PetitionerU.S. Patent 7,595,048
10102022-12-29PetitionerU.S. Application No. 16/006,493
10112022-12-29PetitionerU.S. Provisional Application No. 61/647,442
10122022-12-29PetitionerU.S. Provisional Application No. 61/790,747
10132022-12-29PetitionerOkazaki 2007
10142022-12-29PetitionerIwai 2002
10152022-12-29PetitionerBlank 2005
10162022-12-29PetitionerIwai 2004
10172022-12-29PetitionerBrown 2003
10182022-12-29PetitionerAscierto 2010
10192022-12-29PetitionerBrahmer
10202022-12-29PetitionerNCT ’842
10212022-12-29PetitionerNCT664
10222022-12-29PetitionerHwu 2010
10232022-12-29PetitionerMu
10242022-12-29PetitionerFile History for U.S. Patent No. 10,323,092 B2
10252022-12-29PetitionerTopalian 2011
10262022-12-29PetitionerTopalian 2012
10272022-12-29PetitionerPCT Publication No. WO 2007/005874 A2
10282022-12-29PetitionerTuthill 2009
10292022-12-29PetitionerSznol 2010
10302022-12-29PetitionerU.S. Publication No. US 2010/0055102 A1
10312022-12-29PetitionerErbitux Label
10322022-12-29PetitionerVectibix Label
10332022-12-29PetitionerTysabri Label
10342022-12-29PetitionerFeb. 29, 2000 NIH Press Release
10352022-12-29PetitionerClinicalTrials.gov History, Policies, and Laws
10362022-12-29PetitionerU.S. NAT’L LIBRARY OF MED., NAT’L INST. OF HEALTH, ClinicalTrials.gov...
10372022-12-29PetitionerClinicalTrials.gov Home Page
10382022-12-29PetitionerNCT 664 Protocol
10392022-12-29PetitionerAugust 4, 2008 vs October 27,2009 comparison
10402022-12-29PetitionerLee
10412022-12-29PetitionerClinicalTrials.gov, How to Edit Your Study Record
10422022-12-29PetitionerClinicalTrials.gov, Background
10432022-12-29PetitionerClinicalTrials.gov, Glossary
10442022-12-29PetitionerNCT664 Key Record Dates
10452022-12-29PetitionerNCT664 Landing Page
10462022-12-29PetitionerAugust 4, 2008 vs April 17, 2009 comparison
10472022-12-29PetitionerAugust 4, 2008 vs June 24, 2009 comparison
10482022-12-29PetitionerAugust 4, 2008 vs January 19, 2011 comparison
10492022-12-29PetitionerU.S. Patent No. 10,308,714
10502022-12-29PetitionerU.S. Patent No. 10,266,594
10512022-12-29PetitionerJemal et al., Cancer Statistics, 2009, 59 CA Cancer J. Clin. 225 (2009)
10522022-12-29PetitionerKonishi 2004
10532022-12-29PetitionerU.S. Publication No. US 2009/0055944 A1
10542022-12-29PetitionerU.S. Publication No. US 2011/0250201 A1
10552022-12-29PetitionerU.S. Publication No. US 2011/0244546 A1
10562022-12-29PetitionerWhat is Non-Small Cell Lung Cancer? American Cancer Society (2016)
10572022-12-29PetitionerAuperin 2010
10582022-12-29PetitionerU.S. Publication No. US 2010/0203056 A1
10592022-12-29PetitionerU.S. Patent No. 9,580,505
10602022-12-29PetitionerU.S. Patent No. 9,580,507
10612022-12-29PetitionerIntentionally Omitted
10622022-12-29PetitionerIntentionally Omitted
10632022-12-29PetitionerIntentionally Omitted
10642022-12-29PetitionerIntentionally Omitted
10652022-12-29PetitionerIntentionally Omitted
10662022-12-29PetitionerIntentionally Omitted
10672022-12-29PetitionerIntentionally Omitted
10682022-12-29PetitionerIntentionally Omitted
10692022-12-29PetitionerBrahmer 2012
10702022-12-29PetitionerDecember 5, 2022, Letter to Hon. Kathi Vidal from Senators Warren and...
32023-01-13BoardNotice of Filing DateNotice: Notice filing date accorded
2023-01-19Potential Patent OwnerMandatory NoticeNotice : Mandatory Notice
42023-01-19Potential Patent OwnerMandatory NoticeNotice : Mandatory Notice
52023-01-19Potential Patent OwnerPower of AttorneyNotice : Power of Attorney
62023-02-03PetitionerOtherPetitioner Dana-Farber Cancer Institute, Inc.'s Unopposed Motion for Pro Hac Vice Admission of Katherine A. Helm, J.D., Ph.D.
72023-02-03PetitionerOtherPetitioner Dana-Farber Cancer Institute, Inc.'s Unopposed Motion for Pro Hac Vice Admission of Noah M. Leibowitz
10712023-02-03PetitionerDeclaration of Katherine A. Helm in Support of Motion for Admission Pro Hac Vice
10722023-02-03PetitionerDeclaration of Noah M. Leibowitz in Support of Motion for Admission Pro Hac Vice
82023-02-28BoardOtherDECISION Granting Petitioners Motions for Pro Hac Vice Admission of Katherine A. Helm and Noah M. Leibowitz 37 C.F.R. sec 42.10
92023-04-06PetitionerMotion to TerminateJoint Motion to Terminate Pursuant to 35 U.S.C. § 317
102023-04-06PetitionerOtherJoint Request that the Settlement Agreement be Treated as Business Confidential Information Pursuant to 35 U.S.C. § 317
30012023-04-06BoardExhibit 3001
112023-04-10BoardFinal DecisionTermination Decision: Pre-DI settlement
122023-04-11PetitionerOtherPetitioner's Request for Refund of Post-Institution Fees
132023-04-17BoardOtherNotice: refund approved
Grounds Asserted

Not a member? Sign up for free!